Skila Secures $12 Million in Additional Financing

BancBoston Ventures, Crosslink Capital, and The Sprout Group Lead

Private Financing for Skila



Apr 18, 2001, 01:00 ET from Skila, Inc.

    MAHWAH, N.J., April 18 /PRNewswire/ -- Skila, Inc., the leading provider
 of web-based global knowledge solutions for the pharmaceutical, medical device
 and biotechnology industries, announced today that it closed a $12 million
 private round of financing.  BancBoston Ventures, Crosslink Capital, Inc., and
 The Sprout Group, a venture capital affiliate of Credit Suisse First Boston,
 led the institutional placement.  Skila will use the new financial resources
 to further develop its unique Intelligration(TM) technology, as well as expand
 sales and marketing efforts.
     "In today's competitive marketplace to secure venture capital, our
 strategic investors continue to share Skila's vision about the need and market
 potential for healthcare knowledge solutions," said Moish Tov, chairman of
 Skila.  "With the additional financing, Skila will take advantage of the
 critical mass we have built to rapidly expand our user base and
 fully-integrated global business intelligence, technology and knowledge
 services solutions.  Over the next year, Skila aims to continue to accelerate
 its presence in the healthcare market."
     BancBoston Ventures, Crosslink Capital, and The Sprout Group continue to
 lend their strategic and operational guidance as a critical competitive
 strength to Skila's existing team of healthcare and information technology
 professionals.  "Skila's solutions have come into the market just as the major
 pharmaceutical, medical device and biotechnology companies have come to
 recognize the opportunities created by connectivity, collaboration and
 knowledge sharing across the enterprise," said Philippe Chambon, general
 partner of The Sprout Group.  "The rapid adoption of Skila's solutions has
 validated the market."
 
     About BancBoston Ventures
     BancBoston Ventures, the venture capital investment arm of FleetBoston
 Financial (NYSE:   FBF), has provided expansion capital to emerging growth
 companies since 1959.  Its sister company, BancBoston Capital, provides later
 stage capital options from equity sponsorship to co-investment and mezzanine
 capital for buyouts, recapitalization and expansion of mid-size companies.
 Supported by offices in Boston, Palo Alto, London, Hong Kong, Singapore,
 Buenos Aires and Sao Paulo, BancBoston Capital and BancBoston Ventures have
 invested roughly US$5 billion in more than 500 companies.  Targeting
 opportunities in information technology, medical devices and
 biopharmaceuticals, BancBoston Ventures' healthcare practice has invested in
 Dyax Corporation, Eos Biotechnology, Microbia, Inc., NuGenesis Technologies
 Corporation, Skila, Inc. and Syntonix Pharmaceuticals.  For more information
 on BancBoston Ventures, visit http://www.bancbostonventures.com.
 
     About Crosslink Capital
     Crosslink Capital, Inc. is a leading venture capital firm that merges
 public and private investing.  Crosslink invests in all stages of a company's
 growth, from product development through post-IPO expansion.  The firm's
 private investments are focused at the point of convergence between software,
 services and the Internet.  Crosslink has assembled a best-of-breed management
 team with more than 100 years' collective experience in both venture capital
 and public market investing.  Formerly the Omega Venture arm of Robertson
 Stephens, Crosslink Capital has established itself over the past decade as a
 trusted, long-term partner to its portfolio companies and investors.  Founded
 in 1989, the firm has nearly $1 billion under management in three fund
 families and has made venture capital investments in more than 50 companies.
 
     About The Sprout Group
     The Sprout Group is one of the oldest and largest venture capital firms in
 the US.  Since 1969, Sprout has helped finance more than 300 companies with
 combined sales exceeding $40 billion.  With offices in Menlo Park, New York
 and Chicago, Sprout focuses on helping to grow technology companies in
 communications, e-commerce and e-healthcare.  Active investments include
 AdOutlet.com, Astral Point, Avici, Blue292, BrightLink Networks, CarrierPoint,
 CheMatch, CyOptics Inc., eFinance Corporation, eHealthInsurance.com, Ennovate
 Networks, Excess Bandwidth Corp., FamilyEducation Network (acquired by
 Pearson), Fogdog Sports, GlobeSpan, GroceryWorks.com, Healtheon/WebMD,
 iAsiaWorks, LiquidPrice.com, MarketFirst, Mondera.com, MuseumShop.com, mySimon
 (acquired by CNET), NetEffect Corporation, Netcore Systems (acquired by
 Tellabs), NetLibrary, Paradyne, Perfecto Technologies, Quintus, Rhythms
 NetConnections, Rotor Communications, Silicon Access Networks, Tavolo, Torrent
 Networking Technologies (acquired by Ericsson), and 360networks.  For further
 information on the Sprout Group, please visit their web site at
 http://www.sproutgroup.com.
 
     About Skila
     Skila, Inc., is dedicated to providing turnkey, configurable knowledge
 solutions for the pharmaceutical, medical device and biotechnology industries
 to improve its healthcare partners' critical business processes such as New
 Product Launch, Product Life Cycle Management, Licensing and Lead
 Optimization.  Skila's revolutionary Web-based iWorksite redefines how
 healthcare intelligence decisions are made through an integrated suite of
 decision-enabling applications, relevant market-based intelligence and
 connectivity.  Using Skila's Intelligration(TM) technology, all internal data
 and text-based information throughout an organization and relevant external
 information from key markets around the world are synthesized into complete,
 organized and relevant healthcare intelligence.  Driven by Intelligration(TM),
 clients receive succinct views of actionable intelligence enabling smarter,
 faster and more confident business decisions.
     Skila has strategic relationships with Dendrite(R) International, Inc. and
 Datamonitor, plc.  Skila's investment partners include The Sprout Group (a
 venture capital affiliate of Credit Suisse First Boston Corporation),
 Crosslink Capital, Inc., BancBoston Ventures, Intel Capital and Carlyle
 Venture Partners.  Skila is privately held and headquartered in Mahwah, New
 Jersey, with offices in Somerville, New Jersey, England and Japan.  For more
 information on Skila and its knowledge solutions, please visit them at
 http://www.skila.com.
 
 

SOURCE Skila, Inc.
    MAHWAH, N.J., April 18 /PRNewswire/ -- Skila, Inc., the leading provider
 of web-based global knowledge solutions for the pharmaceutical, medical device
 and biotechnology industries, announced today that it closed a $12 million
 private round of financing.  BancBoston Ventures, Crosslink Capital, Inc., and
 The Sprout Group, a venture capital affiliate of Credit Suisse First Boston,
 led the institutional placement.  Skila will use the new financial resources
 to further develop its unique Intelligration(TM) technology, as well as expand
 sales and marketing efforts.
     "In today's competitive marketplace to secure venture capital, our
 strategic investors continue to share Skila's vision about the need and market
 potential for healthcare knowledge solutions," said Moish Tov, chairman of
 Skila.  "With the additional financing, Skila will take advantage of the
 critical mass we have built to rapidly expand our user base and
 fully-integrated global business intelligence, technology and knowledge
 services solutions.  Over the next year, Skila aims to continue to accelerate
 its presence in the healthcare market."
     BancBoston Ventures, Crosslink Capital, and The Sprout Group continue to
 lend their strategic and operational guidance as a critical competitive
 strength to Skila's existing team of healthcare and information technology
 professionals.  "Skila's solutions have come into the market just as the major
 pharmaceutical, medical device and biotechnology companies have come to
 recognize the opportunities created by connectivity, collaboration and
 knowledge sharing across the enterprise," said Philippe Chambon, general
 partner of The Sprout Group.  "The rapid adoption of Skila's solutions has
 validated the market."
 
     About BancBoston Ventures
     BancBoston Ventures, the venture capital investment arm of FleetBoston
 Financial (NYSE:   FBF), has provided expansion capital to emerging growth
 companies since 1959.  Its sister company, BancBoston Capital, provides later
 stage capital options from equity sponsorship to co-investment and mezzanine
 capital for buyouts, recapitalization and expansion of mid-size companies.
 Supported by offices in Boston, Palo Alto, London, Hong Kong, Singapore,
 Buenos Aires and Sao Paulo, BancBoston Capital and BancBoston Ventures have
 invested roughly US$5 billion in more than 500 companies.  Targeting
 opportunities in information technology, medical devices and
 biopharmaceuticals, BancBoston Ventures' healthcare practice has invested in
 Dyax Corporation, Eos Biotechnology, Microbia, Inc., NuGenesis Technologies
 Corporation, Skila, Inc. and Syntonix Pharmaceuticals.  For more information
 on BancBoston Ventures, visit http://www.bancbostonventures.com.
 
     About Crosslink Capital
     Crosslink Capital, Inc. is a leading venture capital firm that merges
 public and private investing.  Crosslink invests in all stages of a company's
 growth, from product development through post-IPO expansion.  The firm's
 private investments are focused at the point of convergence between software,
 services and the Internet.  Crosslink has assembled a best-of-breed management
 team with more than 100 years' collective experience in both venture capital
 and public market investing.  Formerly the Omega Venture arm of Robertson
 Stephens, Crosslink Capital has established itself over the past decade as a
 trusted, long-term partner to its portfolio companies and investors.  Founded
 in 1989, the firm has nearly $1 billion under management in three fund
 families and has made venture capital investments in more than 50 companies.
 
     About The Sprout Group
     The Sprout Group is one of the oldest and largest venture capital firms in
 the US.  Since 1969, Sprout has helped finance more than 300 companies with
 combined sales exceeding $40 billion.  With offices in Menlo Park, New York
 and Chicago, Sprout focuses on helping to grow technology companies in
 communications, e-commerce and e-healthcare.  Active investments include
 AdOutlet.com, Astral Point, Avici, Blue292, BrightLink Networks, CarrierPoint,
 CheMatch, CyOptics Inc., eFinance Corporation, eHealthInsurance.com, Ennovate
 Networks, Excess Bandwidth Corp., FamilyEducation Network (acquired by
 Pearson), Fogdog Sports, GlobeSpan, GroceryWorks.com, Healtheon/WebMD,
 iAsiaWorks, LiquidPrice.com, MarketFirst, Mondera.com, MuseumShop.com, mySimon
 (acquired by CNET), NetEffect Corporation, Netcore Systems (acquired by
 Tellabs), NetLibrary, Paradyne, Perfecto Technologies, Quintus, Rhythms
 NetConnections, Rotor Communications, Silicon Access Networks, Tavolo, Torrent
 Networking Technologies (acquired by Ericsson), and 360networks.  For further
 information on the Sprout Group, please visit their web site at
 http://www.sproutgroup.com.
 
     About Skila
     Skila, Inc., is dedicated to providing turnkey, configurable knowledge
 solutions for the pharmaceutical, medical device and biotechnology industries
 to improve its healthcare partners' critical business processes such as New
 Product Launch, Product Life Cycle Management, Licensing and Lead
 Optimization.  Skila's revolutionary Web-based iWorksite redefines how
 healthcare intelligence decisions are made through an integrated suite of
 decision-enabling applications, relevant market-based intelligence and
 connectivity.  Using Skila's Intelligration(TM) technology, all internal data
 and text-based information throughout an organization and relevant external
 information from key markets around the world are synthesized into complete,
 organized and relevant healthcare intelligence.  Driven by Intelligration(TM),
 clients receive succinct views of actionable intelligence enabling smarter,
 faster and more confident business decisions.
     Skila has strategic relationships with Dendrite(R) International, Inc. and
 Datamonitor, plc.  Skila's investment partners include The Sprout Group (a
 venture capital affiliate of Credit Suisse First Boston Corporation),
 Crosslink Capital, Inc., BancBoston Ventures, Intel Capital and Carlyle
 Venture Partners.  Skila is privately held and headquartered in Mahwah, New
 Jersey, with offices in Somerville, New Jersey, England and Japan.  For more
 information on Skila and its knowledge solutions, please visit them at
 http://www.skila.com.
 
 SOURCE  Skila, Inc.